Nanomedicine and Nanotechnology
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
”Nanomedicine and Nanotechnology” is a new section of the peer-reviewed open access journal Pharmaceutics, which is focused on all aspects and applications of innovative nanosystems.
The main aims of this section are to highlight and collect recent progress in nanotechnology and its applications in pharmaceutical, clinical, diagnostic, environmental, and cosmetic fields.
Covered topics include the following:
- Advances in methodologies for characterization of nanocarriers
- Nanodevices and nanosensors
- Stability studies
- Development of new drug delivery systems
- Nanotoxicity
- Skin and mucosal application
- Nanotechnology in tissue engineering and regenerative nanomedicine
- Functionalization for a selective target
- Nanodelivery systems in cosmeceutical and nutraceutical field
- Nanodelivery as a strategy to improve bioavailability
- Strategies and formulations for controlled drug release
- In vivo testing
The section encourages the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields. Authors will enjoy a high-quality reviewing process, rapid publication, and high visibility from access to a broad readership.
Review, original research papers, communications, short communications, opinions, or technical notes will be considered for publication.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Nanomedicine and Nanosensors in Cancer Therapies (Deadline: 25 May 2022)
- Nanotechnology Applied in Treatment of Important and Global Parasitic Diseases (Deadline: 31 May 2022)
- Nanovaccine Fight against Infectious Diseases (Deadline: 31 May 2022)
- Recent Developments of Nanovaccine Candidates on Immunology (Deadline: 31 May 2022)
- Nanotechnology Applied to Transdermal Formulations (Deadline: 31 May 2022)
- Functionalized Nanoparticles in Cancer Therapeutics (Deadline: 31 May 2022)
- Polymeric Nanoparticles for Immunotherapy of Cancer (Deadline: 31 May 2022)
- Advances in Parenteral Formulations (Deadline: 31 May 2022)
- Feature Papers in Nanomedicine and Nanotechnology (Deadline: 31 May 2022)
- Encapsulation of Single or Multiple Molecules in Nano- and Microparticles for Drug Delivery (Deadline: 31 May 2022)
- Nanomaterials: Immunological Perspective (Deadline: 10 June 2022)
- Nanotechnology-Enabled Strategies to Enhance Topical Bioavailability (Deadline: 10 June 2022)
- Preclinical Evaluation of Lipid-Based Nanosystems (Volume II) (Deadline: 10 June 2022)
- Biomaterials in Skin Wound Healing and Tissue Regenerations Volume II (Deadline: 10 June 2022)
- Nanomedicine across Barriers (Deadline: 20 June 2022)
- Polymeric Nanoparticles for Cancer Therapy and Biomedical-Related Application (Deadline: 30 June 2022)
- Recent Developments and Emerging Trends in Nanomedicine (Deadline: 30 June 2022)
- Nanoparticles in Ocular Drug Delivery Systems (Deadline: 30 June 2022)
- Targeted Drug Delivery Strategies for Precision Medicines (Deadline: 30 June 2022)
- Recent Trends on Liposome Technology: From Emerging Synthesis Strategies to Advanced Lipid Nanosystems for Drug Delivery (Deadline: 30 June 2022)
- Nanoformulation of Drug Delivery Systems for Natural Products (Deadline: 30 June 2022)
- Functional Polymers in Drug Delivery (Deadline: 30 June 2022)
- Advances in Nanoparticle Delivery for Cancer Immunotherapy (Deadline: 30 June 2022)
- Nanotechnology-Based Approaches for Enhancing Oral Administration of Drugs (Deadline: 10 July 2022)
- Cyclodextrins and Their Inclusion Complexes for Pharmaceutical Uses (Deadline: 10 July 2022)
- Smart Nanomaterials for Diagnosis and Therapy of Diseases (Deadline: 15 July 2022)
- Novel Drug Delivery Nanosystems for Cancer Therapy and Bio-Regeneration (Deadline: 20 July 2022)
- Nanotechnology Applied in Prevention, Diagnosis and Treatment of Infectious Diseases (Deadline: 20 July 2022)
- Ionic Liquid- and Polymer-Based Nanostructures for Pharmaceutical and Biomedical Applications (Deadline: 20 July 2022)
- Advanced Technologies for Developing the State-of-the-Art Nanomedicines (Deadline: 20 July 2022)
- Novel Nano and Microencapsulation Technologies in Pharmaceutics (Deadline: 20 July 2022)
- Fluorescent Organic Nanoparticles for Bioimaging and Theragnostics (Deadline: 25 July 2022)
- Nanoparticle-Mediated Diagnosis and Treatment of Human Disease (Deadline: 28 July 2022)
- Functionalization of Carbon Nanomaterials for Antineoplastic Applications (Deadline: 30 July 2022)
- Innovative Targeted Drug Delivery and Imaging Strategies for Ischemic Myocardial Injuries (Deadline: 31 July 2022)
- Advances in Stimuli-Responsive Tumor Targeting Nanotechnology (Deadline: 31 July 2022)
- Silica Nanoparticles as Delivery Platform for the Treatment of Inflammatory Disorders (Deadline: 31 July 2022)
- Bio-Organic Materials for Tissue Engineering and Regenerative Medicine (Deadline: 31 July 2022)
- Advanced Nanomaterials for Drug Delivery (Deadline: 31 July 2022)
- Nano-Based Approaches for Infectious Diseases (Deadline: 31 July 2022)
- Magnetic Nanoparticles for Therapy and Diagnosis in Nanomedicine (Deadline: 31 July 2022)
- Multifunctional Nanoparticles for Drug Delivery and Tissue Engineering Applications (Deadline: 31 July 2022)
- Drug Nanocrystals (Deadline: 31 July 2022)
- Bioconjugation and Nanomaterials for Clinical Translation (Deadline: 31 July 2022)
- Nanoparticle Delivery to Tumors: Challenges and Advances (Deadline: 31 July 2022)
- Graphene-Based Nanomaterials in Drug Delivery Systems (Deadline: 31 July 2022)
- Magnetic Nanomaterials – a Promising Approach in Cancer Therapy (Deadline: 10 August 2022)
- Nanocarriers for Drug Delivery and/or Gene Therapy in Cancer (Deadline: 10 August 2022)
- On the Road to Precision Medicine: Magnetic Systems for Tissue Regeneration, Drug Delivery, Imaging, and Theranostics (Deadline: 15 August 2022)
- Development of Novel Nanomedicines for Combination Therapy and Theranostic Applications (Deadline: 20 August 2022)
- Stimuli-Responsive Nanomedicine for the Effective and Controlled Delivery of Drug Molecules to the Tumor Microenvironment (Deadline: 20 August 2022)
- Development of Novel Tumor-Targeting Nanoparticles (Deadline: 20 August 2022)
- Recent Advances in Biomimetic Nanotechnology for Cancer Immunotherapy (Deadline: 20 August 2022)
- Recent Advances in Dendrimer Nanomedicine (Deadline: 20 August 2022)
- Recent Advances in Antifungal Drugs (Deadline: 30 August 2022)
- Nanoparticles and Materials Design for Nervous System Diseases (Deadline: 30 August 2022)
- Organic-Inorganic Nanocomposites as Delivery Systems of Therapeutic Agents for Regenerative Medicine (Deadline: 31 August 2022)
- Nano/Microparticle Technologies in Nonbiological Complex Drugs (Deadline: 31 August 2022)
- Porous Nanomaterials for Tissue Engineering and Drug Delivery (Deadline: 31 August 2022)
- Metal-Based Nanoparticles for Pharmaceutical Applications (Deadline: 31 August 2022)
- Nanotechnology in Ocular Drug Delivery (Deadline: 31 August 2022)
- Nanocrystals for Drug Delivery (Deadline: 31 August 2022)
- Metal Nanoparticles for Cancer Therapy (Deadline: 31 August 2022)
- Curcumin in Biomedical Applications (Deadline: 31 August 2022)
- Study of Nanoparticles for Photodynamic Therapy and Imaging (Deadline: 10 September 2022)
- Selective Antitumor Therapy Based on Nanotechnology (Deadline: 15 September 2022)
- Gold Nanoparticles for Biomedical Application (Deadline: 20 September 2022)
- Bioactive Materials in Drug-Delivery Systems (Deadline: 20 September 2022)
- Mesoporous Silica Nanoparticles: Smart Delivery Platform (Deadline: 30 September 2022)
- New Properties of Supramolecular Complexes and Drug Nanoparticles (Deadline: 30 September 2022)
- Ionic Liquids in Pharmaceutical and Biomedical Applications (Deadline: 10 October 2022)
- Application of Nanoparticles and Dendrimers for Treating Infectious Diseases (Deadline: 20 October 2022)
- Polymeric Carriers for Controlled Drug Release (Deadline: 31 October 2022)
- Stimuli-Sensitive Materials for Biomedical and Pharmaceutical Applications (Deadline: 10 November 2022)
- Applications of Mesoporous Silica Nanoparticles (MSNs) in Innovative Drug Delivery and Therapeutics (Deadline: 15 November 2022)
- Micro/Nano Droplets/Bubbles for Therapy, Diagnosis and Theranostics (Deadline: 30 November 2022)
- Novel Nanoparticles for Photothermal and Photodynamic Therapy (Deadline: 1 December 2022)
- Nanofibrous Scaffolds: Promising Wound Dressing Materials (Deadline: 30 December 2022)
- Advances in Nanocarriers for Drug Delivery and Targeting (Deadline: 31 December 2022)
- Nanomedicines for Nucleic Acid Delivery (Deadline: 31 March 2023)
